Royalty Pharma plc (RPRX) Net margin 2018–2025
Royalty Pharma plc (RPRX) net profit margin by fiscal year — reported net income divided by reported revenue.
32.4%FY2025 · since FY2018: 76.8% → 32.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 32.4% | -5.5 pp |
| FY2024 | 37.9% | -10.2 pp |
| FY2023 | 48.2% | +46.3 pp |
| FY2022 | 1.9% | -25.2 pp |
| FY2021 | 27.1% | -18.9 pp |
| FY2020 | 45.9% | -83.5 pp |
| FY2019 | 129.4% | +52.7 pp |
| FY2018 | 76.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice